$VRME
VerifyMe Inc

2015 Q4 Form 10-Q Financial Statement

#000119312515375915 Filed on November 12, 2015

View on sec.gov

Income Statement

Concept 2015 Q4 2015 Q3 2015 Q2
Revenue $0.00 $142.6K $68.38K
YoY Change -100.0% 167.82% 4.95%
Cost Of Revenue $0.00 $28.69K $36.08K
YoY Change -100.0% -42.81% -33.73%
Gross Profit $0.00 $114.0K $32.30K
YoY Change 3575.9% 201.61%
Gross Profit Margin 79.89% 47.23%
Selling, General & Admin $1.040M $253.0K $80.45K
YoY Change 121.28% 14.32% -77.02%
% of Gross Profit 222.0% 249.1%
Research & Development $220.0K $58.42K $2.016M
YoY Change -97.73% -45.24% 2303.23%
% of Gross Profit 51.26% 6242.26%
Depreciation & Amortization $30.00K $17.39K $17.31K
YoY Change 50.0% 0.47% 0.0%
% of Gross Profit 15.26% 53.61%
Operating Expenses $1.260M $1.229M $2.433M
YoY Change -87.23% 101.82% 173.27%
Operating Profit -$1.260M -$1.115M -$2.401M
YoY Change -87.23% 84.05% 172.93%
Interest Expense $30.00K $4.284K $24.90K
YoY Change -99.12% -94.88% 89.8%
% of Operating Profit
Other Income/Expense, Net $1.332M $1.444M
YoY Change -220.19% -68.13%
Pretax Income -$1.300M $220.0K -$960.0K
YoY Change -79.78% -112.87% -126.3%
Income Tax $0.00 $0.00
% Of Pretax Income 0.0%
Net Earnings -$1.300M $216.3K -$956.3K
YoY Change -79.78% -112.62% -126.19%
Net Earnings / Revenue 151.66% -1398.65%
Basic Earnings Per Share $0.04 -$0.24
Diluted Earnings Per Share -$10.83M $0.03 -$0.24
COMMON SHARES
Basic Shares Outstanding 5.977M shares 5.859M shares 3.934M shares
Diluted Shares Outstanding 7.462M shares 3.934M shares

Balance Sheet

Concept 2015 Q4 2015 Q3 2015 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $0.00 $280.0K $1.010M
YoY Change -100.0% 818.18%
Cash & Equivalents $4.152K $278.0K $1.011M
Short-Term Investments
Other Short-Term Assets $0.00 $170.0K $180.0K
YoY Change -100.0% -5.56% 0.0%
Inventory $28.69K $98.58K $74.58K
Prepaid Expenses $171.1K $178.7K
Receivables $69.24K $62.13K
Other Receivables $0.00 $0.00
Total Short-Term Assets $32.84K $616.8K $1.326M
YoY Change -90.41% 76.24% 208.36%
LONG-TERM ASSETS
Property, Plant & Equipment $7.838K $25.23K $40.19K
YoY Change -89.52% -71.96% -63.46%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $296.5K $132.3K $136.6K
YoY Change 104.78% 230.69% 241.42%
Total Long-Term Assets $304.3K $157.5K $176.8K
YoY Change 38.58% -34.37% -34.53%
TOTAL ASSETS
Total Short-Term Assets $32.84K $616.8K $1.326M
Total Long-Term Assets $304.3K $157.5K $176.8K
Total Assets $337.2K $774.3K $1.503M
YoY Change -40.01% 31.24% 114.67%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $650.0K $510.0K $740.0K
YoY Change -87.55% 8.51% 80.49%
Accrued Expenses $0.00 $0.00
YoY Change -100.0% -100.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Long-Term Debt Due $50.00K $50.00K $0.00
YoY Change -92.75% -90.2% -100.0%
Total Short-Term Liabilities $2.505M $559.5K $740.2K
YoY Change -59.62% -63.19% -17.76%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Other Long-Term Liabilities $1.830M $3.180M
YoY Change -60.98% -15.2%
Total Long-Term Liabilities $0.00 $1.830M $3.183M
YoY Change -100.0% -61.88% -17.55%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.505M $559.5K $740.2K
Total Long-Term Liabilities $0.00 $1.830M $3.183M
Total Liabilities $2.510M $2.389M $3.923M
YoY Change -80.22% -62.26% -17.59%
SHAREHOLDERS EQUITY
Retained Earnings -$40.00M -$38.70M -$38.92M
YoY Change 6.11%
Common Stock $5.977K $5.909K $5.502K
YoY Change 65.2%
Preferred Stock
YoY Change
Treasury Stock (at cost) $113.4K $113.4K $113.4K
YoY Change 0.0%
Treasury Stock Shares
Shareholders Equity -$2.168M -$1.615M -$2.420M
YoY Change
Total Liabilities & Shareholders Equity $337.2K $774.3K $1.503M
YoY Change -40.01% 31.24% 114.67%

Cashflow Statement

Concept 2015 Q4 2015 Q3 2015 Q2
OPERATING ACTIVITIES
Net Income -$1.300M $216.3K -$956.3K
YoY Change -79.78% -112.62% -126.19%
Depreciation, Depletion And Amortization $30.00K $17.39K $17.31K
YoY Change 50.0% 0.47% 0.0%
Cash From Operating Activities -$280.0K -$680.0K -$410.0K
YoY Change 211.11% 36.0% -43.06%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00 $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $50.00K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 -50.00K 1.350M
YoY Change -100.0% -112.5% 440.0%
NET CHANGE
Cash From Operating Activities -280.0K -680.0K -410.0K
Cash From Investing Activities 0.000 0.000 0.000
Cash From Financing Activities 0.000 -50.00K 1.350M
Net Change In Cash -280.0K -730.0K 940.0K
YoY Change -566.67% 630.0% -300.0%
FREE CASH FLOW
Cash From Operating Activities -$280.0K -$680.0K -$410.0K
Capital Expenditures $0.00 $0.00 $0.00
Free Cash Flow -$280.0K -$680.0K -$410.0K
YoY Change 211.11% -43.06%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
5976687 shares
CY2015Q2 vrme Reverse Stock Split Ratio
ReverseStockSplitRatio
85 pure
CY2015Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
304785 shares
CY2015Q2 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
317000
CY2015Q2 us-gaap Interest Payable Current
InterestPayableCurrent
42713
CY2015Q2 vrme Fair Value Of Warrants
FairValueOfWarrants
1867417
CY2015Q2 vrme Number Of Shareholders
NumberOfShareholders
3 Shareholder
CY2015Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
675000000 shares
CY2015Q3 us-gaap Capital Units Authorized
CapitalUnitsAuthorized
750000000 shares
CY2015Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
75000000 shares
CY2014Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3605
CY2015Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
675000000 shares
CY2015Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5909187 shares
CY2015Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2015Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6259727 shares
CY2015Q3 us-gaap Treasury Stock Number Of Shares Held
TreasuryStockNumberOfSharesHeld
350540 shares
CY2015Q3 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
31605
CY2015Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1829757
CY2015Q3 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
50568
CY2015Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
0
CY2015Q3 us-gaap Stockholders Equity
StockholdersEquity
-1614898
CY2015Q3 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
18963
CY2015Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
39120912
CY2015Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
131111
CY2015Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
509485
CY2015Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
1829757
CY2015Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-38700030
CY2015Q3 us-gaap Liabilities
Liabilities
2389242
CY2015Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
774344
CY2015Q3 us-gaap Shareholders Equity Fair Value Disclosure
ShareholdersEquityFairValueDisclosure
81000
CY2015Q3 us-gaap Common Stock Value
CommonStockValue
5909
vrme Fair Value Of Options Issued In Exchange For Services
FairValueOfOptionsIssuedInExchangeForServices
400721
CY2015Q3 us-gaap Assets
Assets
774344
CY2015Q3 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
0
CY2015Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2015Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
213226
CY2015Q3 us-gaap Notes Payable
NotesPayable
50000
CY2015Q3 us-gaap Liabilities Current
LiabilitiesCurrent
559485
CY2015Q3 us-gaap Notes Payable Current
NotesPayableCurrent
50000
CY2015Q3 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
18587
CY2015Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
132274
CY2015Q3 us-gaap Assets Fair Value Disclosure Recurring
AssetsFairValueDisclosureRecurring
0
CY2015Q3 us-gaap Inventory Net
InventoryNet
98581
CY2015Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
69237
CY2015Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
25232
CY2015Q3 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
37197
CY2015Q3 us-gaap Treasury Stock Value
TreasuryStockValue
113389
CY2015Q3 us-gaap Assets Current
AssetsCurrent
616838
CY2015Q3 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
219871
CY2015Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
95077
CY2015Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
171053
CY2015Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
277967
CY2015Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
238458
CY2015Q3 us-gaap Deferred Compensation Equity
DeferredCompensationEquity
1928742
CY2015Q3 vrme Employee Share Based Compensation Arrangement By Share Based Payment Award Options And Warrants Exercisable Weighted Average Exercise Price
EmployeeShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndWarrantsExercisableWeightedAverageExercisePrice
3.62
CY2015Q3 vrme Employee Share Based Compensation Arrangement By Share Based Payment Award Options And Warrants Outstanding Weighted Average Exercise Price
EmployeeShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndWarrantsOutstandingWeightedAverageExercisePrice
1.97
CY2015Q3 vrme Assets And Liabilities Measured At Fair Value On Nonrecurring Basis
AssetsAndLiabilitiesMeasuredAtFairValueOnNonrecurringBasis
0
CY2015Q3 vrme Warrants Liability
WarrantsLiability
1829757
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1285973
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
675000000 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3618566 shares
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3969106 shares
CY2014Q4 us-gaap Treasury Stock Number Of Shares Held
TreasuryStockNumberOfSharesHeld
350540 shares
CY2014Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
6483594
CY2014Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
114000
CY2014Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
0
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
-12125793
CY2014Q4 us-gaap Accounts Payable And Accrued Liabilities Noncurrent
AccountsPayableAndAccruedLiabilitiesNoncurrent
112885
CY2014Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
25047050
CY2014Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
118502
CY2014Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
5217770
CY2014Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2014Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
16667
CY2014Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
6370709
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-1932368
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3559528 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3559528 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.42
us-gaap Net Income Loss
NetIncomeLoss
-1491780
CY2014Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
43215
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-37696405
CY2014Q4 us-gaap Liabilities
Liabilities
12687799
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
562006
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
3618
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2014Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
161205
CY2014Q4 us-gaap Notes Payable
NotesPayable
926553
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
6204205
CY2014Q4 us-gaap Notes Payable Current
NotesPayableCurrent
812553
CY2014Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
16155
CY2014Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
144783
CY2014Q4 us-gaap Assets
Assets
562006
CY2014Q4 us-gaap Inventory Net
InventoryNet
97360
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
74821
CY2014Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
10447
CY2014Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
37197
CY2014Q4 us-gaap Treasury Stock Value
TreasuryStockValue
113389
CY2014Q4 us-gaap Assets Current
AssetsCurrent
342402
CY2014Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
219871
CY2014Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
107586
CY2014Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
181086
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
63956
CY2014Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
236026
CY2014Q4 vrme Employee Share Based Compensation Arrangement By Share Based Payment Award Options And Warrants Outstanding Weighted Average Exercise Price
EmployeeShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndWarrantsOutstandingWeightedAverageExercisePrice
4.25
CY2014Q4 vrme Warrants Liability
WarrantsLiability
6370709
CY2015Q2 us-gaap Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
525000 shares
CY2015Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
50000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.42
us-gaap Sales Revenue Net
SalesRevenueNet
118408
us-gaap Operating Income Loss
OperatingIncomeLoss
-3714378
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
100173
us-gaap Income Taxes Paid
IncomeTaxesPaid
0
us-gaap Gross Profit
GrossProfit
13808
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2222598
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
22936
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-7896
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-82000
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
118408
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
166475
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-1282368
us-gaap Operating Expenses
OperatingExpenses
3728186
us-gaap Interest Expense
InterestExpense
107691
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
650000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1055290
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
256551
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
420937
us-gaap Professional Fees
ProfessionalFees
341912
us-gaap Cost Of Goods Sold
CostOfGoodsSold
104600
us-gaap Depreciation And Amortization
DepreciationAndAmortization
61771
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
650000
us-gaap Depreciation
Depreciation
51940
vrme Change In Fair Value Of Warrants
ChangeInFairValueOfWarrants
2012289
vrme Fair Value Of Stock In Excess Of Converted Notes Payable And Accrued Interest
FairValueOfStockInExcessOfConvertedNotesPayableAndAccruedInterest
82000
vrme Payroll Expenses
PayrollExpenses
1743572
vrme Fair Value Of Options Issued In Exchange For Services
FairValueOfOptionsIssuedInExchangeForServices
842592
vrme Stock And Warrants Issued In Exchange For Technology
StockAndWarrantsIssuedInExchangeForTechnology
844000
vrme Fair Value Of Warrants Issued As Debt Discount
FairValueOfWarrantsIssuedAsDebtDiscount
151005
vrme Fair Value Of Stock Issued For Conversion Of Notes Payable And Accrued Interest
FairValueOfStockIssuedForConversionOfNotesPayableAndAccruedInterest
506588
vrme Change In Fair Value Of Embedded Derivative Liability
ChangeInFairValueOfEmbeddedDerivativeLiability
-400000
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.22
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-1221500
us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
0
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 Segment
us-gaap Description Of New Accounting Pronouncements Not Yet Adopted
DescriptionOfNewAccountingPronouncementsNotYetAdopted
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt"> <b><i><u>Recently Issued Accounting Pronouncements Not Yet Adopted</u></i></b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"> As of September&#xA0;30, 2015, there are no recently issued accounting standards not yet adopted which would have a material effect on the Company&#x2019;s financial statements through 2017.</p> </div>
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001104038
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
-2642138
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Registrant Name
EntityRegistrantName
VerifyMe, Inc.
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4474383 shares
us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> <b><i><u>Use of Estimates</u></i></b></p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates.</p> </div>
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <b><i><u>Reclassifications</u></i></b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"> Certain amounts in the 2014 statement of operations have been reclassified in order for them to conform with the 2015 presentation.</p> </div>
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4474383 shares
dei Document Period End Date
DocumentPeriodEndDate
2015-09-30
dei Trading Symbol
TradingSymbol
VRME
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.22
us-gaap Property Plant And Equipment Depreciation Methods
PropertyPlantAndEquipmentDepreciationMethods
Straight-line method
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
50000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2432
us-gaap Net Income Loss
NetIncomeLoss
-1003625
us-gaap Sales Revenue Net
SalesRevenueNet
217267
us-gaap Interest Paid
InterestPaid
6646
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
100
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
50000
us-gaap Operating Income Loss
OperatingIncomeLoss
-3918848
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1221
us-gaap Income Taxes Paid
IncomeTaxesPaid
0
us-gaap Gross Profit
GrossProfit
152499
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2915223
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
400721
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
69237
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-10033
us-gaap Royalty Revenue
RoyaltyRevenue
16667
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
332523
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
200600
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
631678
us-gaap Accretion Of Discount
AccretionOfDiscount
10447
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-16667
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
60316
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
214011
us-gaap Operating Expenses
OperatingExpenses
4071347
us-gaap Interest Expense
InterestExpense
59438
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-2532
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
1438043
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2194801
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
50000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2155173
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
349055
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
379817
us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
633333
us-gaap Professional Fees
ProfessionalFees
398941
us-gaap Cost Of Goods Sold
CostOfGoodsSold
64768
vrme Licensing Fees
LicensingFees
2000000
vrme Employee Share Based Compensation Arrangement By Share Based Payment Award Options And Warrants Forfeitures In Period Weighted Average Exercise Price
EmployeeShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndWarrantsForfeituresInPeriodWeightedAverageExercisePrice
0
us-gaap Depreciation And Amortization
DepreciationAndAmortization
64629
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
159542
us-gaap Depreciation
Depreciation
52021
us-gaap Restricted Stock Expense
RestrictedStockExpense
43386
us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
1278501
vrme Change In Fair Value Of Warrants
ChangeInFairValueOfWarrants
2642138
vrme Stock Issued During Period Value Conversion Of Deferred Compensation
StockIssuedDuringPeriodValueConversionOfDeferredCompensation
35000
vrme Payroll Expenses
PayrollExpenses
1037472
vrme Employee Share Based Compensation Arrangement By Share Based Payment Award Options And Warrants Exercises In Period Weighted Average Exercise Price
EmployeeShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndWarrantsExercisesInPeriodWeightedAverageExercisePrice
0
vrme Conversion Of Warrants To Common Stock
ConversionOfWarrantsToCommonStock
37000
vrme Noncash Exercise Of Common Stock Warrants
NoncashExerciseOfCommonStockWarrants
2
vrme Fair Value Of Stock Issued For Conversion Of Notes Payable And Accrued Interest
FairValueOfStockIssuedForConversionOfNotesPayableAndAccruedInterest
731426
vrme Forgiveness Of Debt Related Party Treated As Additional Paid In Capital
ForgivenessOfDebtRelatedPartyTreatedAsAdditionalPaidInCapital
175287
vrme Convertible Preferred Stock Issued During Period Value New Issues
ConvertiblePreferredStockIssuedDuringPeriodValueNewIssues
1278501
vrme Employee Share Based Compensation Arrangement By Share Based Payment Award Options And Warrants Grants In Period Weighted Average Exercise Price
EmployeeShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndWarrantsGrantsInPeriodWeightedAverageExercisePrice
1.25
vrme Amortization Of Deferred Compensation
AmortizationOfDeferredCompensation
202908
vrme Number Of Financial Institutions At Which Cash And Cash Equivalent Are Held
NumberOfFinancialInstitutionsAtWhichCashAndCashEquivalentAreHeld
1 Institution
vrme Stock Issued During Period Value Conversion Of Convertible Warrants
StockIssuedDuringPeriodValueConversionOfConvertibleWarrants
37000
vrme Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value Conversion Of Notes Payable
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValueConversionOfNotesPayable
31397
vrme Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value Conversion Of Warrants Related To Licensing Fees
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValueConversionOfWarrantsRelatedToLicensingFees
1867417
vrme Stock Issued During Period Value Conversion Of Accrued Expenses
StockIssuedDuringPeriodValueConversionOfAccruedExpenses
8367417
vrme Adjustment To Additional Paid In Capital Amortization Of Deferred Compensation
AdjustmentToAdditionalPaidInCapitalAmortizationOfDeferredCompensation
202908
vrme Gains Losses On Conversion Of Debt
GainsLossesOnConversionOfDebt
332523
vrme Conversion For Deferred Compensation To Preferred Stock
ConversionForDeferredCompensationToPreferredStock
35000
vrme Conversion Of Convertible Notes Payable And Accrued Interest To Preferred Stock
ConversionOfConvertibleNotesPayableAndAccruedInterestToPreferredStock
136813
vrme Conversion For Accrued License Fees To Preferred Stock
ConversionForAccruedLicenseFeesToPreferredStock
6500000
vrme Conversion For Deferred Compensation To Common Stock
ConversionForDeferredCompensationToCommonStock
2131650
vrme Forgiveness Of Stockholder Compensation
ForgivenessOfStockholderCompensation
175287
vrme Debt Conversion Converted Preferred Stock Amount
DebtConversionConvertedPreferredStockAmount
136813
vrme Debt Conversion Converted Common Stock Amount
DebtConversionConvertedCommonStockAmount
99447
vrme Conversion Of Warrants To Convertible Preferred Stock
ConversionOfWarrantsToConvertiblePreferredStock
1867417
vrme Conversion Of Accounts Payable And Accrued Expenses Into Common Stock
ConversionOfAccountsPayableAndAccruedExpensesIntoCommonStock
99447
vrme Stock Issued During Period Value Conversion Of Notes Payable And Accrued Interest
StockIssuedDuringPeriodValueConversionOfNotesPayableAndAccruedInterest
731426
CY2014 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
494939
CY2014 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2014Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.47
CY2014Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3618566 shares
CY2014Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3618566 shares
CY2014Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.47
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
-1713915
CY2015Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
19237648 shares
CY2015Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7462128 shares
CY2014Q3 us-gaap Sales Revenue Net
SalesRevenueNet
53260
CY2014Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-605969
CY2014Q3 us-gaap Gross Profit
GrossProfit
3100
CY2014Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1107946
CY2014Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
53260
CY2014Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2014Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
40656
CY2014Q3 us-gaap Operating Expenses
OperatingExpenses
609069
CY2014Q3 us-gaap Interest Expense
InterestExpense
83663
CY2014Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
106674
CY2014Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
180626
CY2014Q3 us-gaap Professional Fees
ProfessionalFees
50714
CY2014Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
50160
CY2014Q3 us-gaap Depreciation
Depreciation
17313
CY2014Q3 vrme Change In Fair Value Of Warrants
ChangeInFairValueOfWarrants
-824283
CY2014Q3 vrme Payroll Expenses
PayrollExpenses
230399
CY2014Q3 vrme Change In Fair Value Of Embedded Derivative Liability
ChangeInFairValueOfEmbeddedDerivativeLiability
200000
CY2015Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
CY2015Q3 us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
0
CY2015Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5859187 shares
CY2015Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
CY2015Q3 us-gaap Net Income Loss
NetIncomeLoss
216337
CY2015Q3 us-gaap Sales Revenue Net
SalesRevenueNet
142642
CY2015Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1115277
CY2015Q3 us-gaap Gross Profit
GrossProfit
113953
CY2015Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1331614
CY2015Q3 us-gaap Royalty Revenue
RoyaltyRevenue
4167
CY2015Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-19395
CY2015Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
138475
CY2015Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2015Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
37189
CY2015Q3 us-gaap Operating Expenses
OperatingExpenses
1229230
CY2015Q3 us-gaap Interest Expense
InterestExpense
4284
CY2015Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
58415
CY2015Q3 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
314960
CY2015Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
215787
CY2015Q3 us-gaap Professional Fees
ProfessionalFees
170506
CY2015Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
28689
CY2015Q3 us-gaap Depreciation
Depreciation
17394
CY2015Q3 us-gaap Restricted Stock Expense
RestrictedStockExpense
37188
CY2015Q3 vrme Change In Fair Value Of Warrants
ChangeInFairValueOfWarrants
1355293
CY2015Q3 vrme Payroll Expenses
PayrollExpenses
747333
CY2015Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
2353 shares

Files In Submission

Name View Source Status
0001193125-15-375915-index-headers.html Edgar Link pending
0001193125-15-375915-index.html Edgar Link pending
0001193125-15-375915.txt Edgar Link pending
0001193125-15-375915-xbrl.zip Edgar Link pending
d55765d10q.htm Edgar Link pending
d55765dex311.htm Edgar Link pending
d55765dex312.htm Edgar Link pending
d55765dex321.htm Edgar Link pending
d55765dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
vrme-20150930.xml Edgar Link completed
vrme-20150930.xsd Edgar Link pending
vrme-20150930_cal.xml Edgar Link unprocessable
vrme-20150930_def.xml Edgar Link unprocessable
vrme-20150930_lab.xml Edgar Link unprocessable
vrme-20150930_pre.xml Edgar Link unprocessable